Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation

Min Zhuo, Yinghe Hu, Carsten Schultz, Eric R. Kandel, Robert D. Hawkins

Research output: Contribution to journalArticlepeer-review

369 Scopus citations


SEVERAL lines of evidence suggest that cyclic GMP might be involved in long-term potentiation (LTP) in the hippocampus1-6. Arachidonic acid, nitric oxide and carbon monoxide, three molecules that have been proposed to act as retrograde messengers in LTP7-9, all activate soluble guanylyl cyclase1,10,11. We report here that an inhibitor of guanylyl cyclase blocks the induction of LTP in the CA1 region of hippocampal slices. Conversely, cGMP analogues produce long-lasting enhancement of the excitatory postsyn-aptic potential if they are applied at the same time as weak tetanic stimulation of the presynaptic fibres. The enhancement is spatially restricted, is not blocked by valeric acid (APV), nifedipine, or picrotoxin, and partially occludes LTP. This synaptic enhancement may be mediated by the cGMP-dependent protein kinase (PKG). Inhibitors of PKG block the induction of LTP, and activators of PKG produce activity-dependent long-lasting enhancement. These results suggest that guanylyl cyclase and PKG contribute to LTP, possibly as activity-dependent presynaptic effectors of retrograde messengers.

Original languageEnglish (US)
Pages (from-to)635-639
Number of pages5
Issue number6472
StatePublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation'. Together they form a unique fingerprint.

Cite this